Diabetes mellitus (DM) with chronic kidney disease (CKD) creates a high-risk “triple threat” with dyslipidaemia, driving an atherogenic lipid profile that accelerates atherosclerosis and raises cardiovascular morbidity and mortality. A review of diabetic kidney disease shows altered lipid metabolism from insulin resistance, inflammation, and oxidative stress — and that while statins remain foundational, added agents such as ezetimibe, PCSK9 inhibitors, and bempedoic acid can further reduce cardiovascular risk in CKD.

Why It Matters To Your Practice

• NPs and PAs are often the first clinicians to spot this cardio-kidney-metabolic overlap before it becomes a hospitalization.

• Patients with DM and CKD may have residual lipid risk even when standard LDL-focused treatment is already in place.

• Advanced CKD can blunt the cardiovascular benefit seen with statins alone, making medication intensification and follow-up especially important.

Clinical Benefits

• Recognizing the atherogenic pattern early can support more aggressive cardiovascular risk reduction.

• Combination therapy with ezetimibe or newer nonstatin agents may help lower risk beyond statin monotherapy in appropriate CKD patients.

• Your frontline medication reviews, lab surveillance, and adherence coaching can directly shape outcomes in this vulnerable group.

Managing Risks

• Monitor kidney function, lipid trends, comorbid burden, and polypharmacy when escalating therapy.

• Residual lipid abnormalities may persist despite traditional treatment, so reassess rather than assume LDL control means total risk control.

• Emerging therapies are promising, but longer-term outcomes data in patients with both DM and CKD are still needed.

The Bottom Line

• DM plus CKD is a potent driver of atherogenic dyslipidaemia and cardiovascular risk.

• Statins still matter, but many patients may benefit from a broader lipid-lowering strategy.

• NPs and PAs are not “backup” here — your early recognition, treatment escalation, and continuity of care are central to preventing events and improving survival.